Standout Papers

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated... 2003 2026 2010 2018 608
  1. Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis (2003)
    Chantal Valiquette, Isabelle Rocher et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages
2025 Standout
Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles
2024 Standout
11 intermediate papers

Works of Chantal Valiquette being referenced

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
2003 Standout

Author Peers

Author Last Decade Papers Cites
Chantal Valiquette 435 316 158 200 12 700
Cary R. Chrisman 337 258 128 211 10 670
Jennifer L. Stotka 186 267 44 133 17 745
P. R. Somasundaram 537 378 342 143 42 849
Kemal Tahaoğlu 491 371 303 73 15 661
Jean W. Lee 355 211 37 123 9 839
Kari T Kivist 226 155 98 403 8 836
Belle L. Lee 428 212 25 153 15 820
Line Labbé 350 83 41 171 21 733
Abiy Habtewold 354 167 33 264 25 704
Carol Braun Trapnell 200 160 90 99 23 691

All Works

Loading papers...

Rankless by CCL
2026